Sage Investment Counsel’s Pfizer PFE Stock Holding History

Sage Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,013	Closed	-$213K	–	131
2024 Q4	$213K	Buy	+8,013	New	+$217K	0.28%	99

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sage Investment Counsel's PFE Position: Q1 2025 in Review

Sage Investment Counsel sold out of Pfizer (PFE) in Q1 2025, closing a stake of 8,013 shares — an estimated $213K sold.

Sage Investment Counsel first reported a position in PFE in Q4 2024 and held it in 1 quarter. The position peaked at $213K in Q4 2024. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

Sage Investment Counsel reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
Sage Investment Counsel sold 8,013 Pfizer shares in Q1 2025, an estimated $213K.
Sage Investment Counsel first reported a position in Pfizer in Q4 2024 and held it in 1 quarter.
Sage Investment Counsel's Pfizer position peaked at $213K in Q4 2024.
2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Sage Investment Counsel's 13F filing for Q1 2025, filed 23 Apr 2025.